SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-20-002392
Filing Date
2020-02-03
Accepted
2020-02-03 16:03:21
Documents
2
Group Members
VIVO OPPORTUNITY, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g0120vivo_trilliumtherap.htm SC 13G 66322
2 JOINT FILING AGREEMENT sc13g0120ex99-1vivo_trillium.htm EX-99.1 4723
  Complete submission text file 0001213900-20-002392.txt   72507
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Subject) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: SC 13G | Act: 34 | File No.: 005-88719 | Film No.: 20568644
SIC: 2834 Pharmaceutical Preparations

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Capital IX, LLC (Filed by) CIK: 0001750698 (see all company filings)

IRS No.: 824768569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G